Broad-spectrum cancer drugs are versatile in treating various types of cancer. Therefore, doctors should carefully evaluate the patient's specific cancer subtype and overall condition when selecting and modifying treatment strategies.
Because broad-spectrum anticancer drugs may act on many different physiological processes, side effects can be more complex and varied.
Common side effects include fatigue, rash, gastrointestinal symptoms (e.g., nausea, vomiting, diarrhea), immune-related side effects (e.g., inflammation, endocrine disorders), etc. These side effects need to be monitored and managed regularly.
Individualized dosage adjustments of broad-spectrum anticancer drugs should be based on factors such as the patient's weight, age, liver and kidney function to optimize treatment efficacy.
Resistance to broad-spectrum anticancer drugs may develop during treatment, necessitating regular assessment of treatment outcomes. If resistance is detected, treatment adjustment should be promptly considered.